Keywords: ACC; acetyl-CoA carboxylase; ACE; angiotensin-converting enzyme; AICAR; 5-aminoimidazole-4-carboxamide ribonucleotide; ALDH2; aldehyde dehydrogenase 2; AMPK; 5' AMP-activated protein kinase; ATP; adenosine triphosphate; Bax; Bcl-2-like protein 4; BNIP3; B
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AGO; Argonaute; ARG1; arginase1; ATM; adipose tissue macrophage; BAT; brown adipose tissue; BMDM; bone marrow derived macrophage; C/EBP; CCAAT-enhancer-binding proteins; CCL2; C-C Motif Chemokine Ligand 2; CCR2; C-C Motif Chemokine Receptor 2; CLS; crown-
Keywords: Oral galactose; Streptozotocin; Intracerebroventricular; Sporadic Alzheimer's disease; Memory; Glucagon-like peptide-1; 18fluorodeoxyglucose; APP; amyloid precursor protein; ATP; adenosine triphosphate; Aβ1-42; amyloid β 1-42; CMRgl; cerebral metabolic
Keywords: ABCA1; ATP-binding cassette transporter; ACOG; American College of Obstetricians and Gynecologists; ACSM; American College of Exercise Medicine; AMPK; AMP-activate protein kinase; ADA; American Diabetes Association; BMI; body mass index; BMR; Basal metabo
Keywords: Alzheimer's disease; Diabetes; Insulin resistance; Inflammation; Gangliosides; mTOR; PTP1B; AβOs; Aβ peptide oligomers; AD; Alzheimer's disease; APP; amyloid precursor protein; AICD; amyloid precursor protein intracellular domain; BDNF; brain-derived ne
Keywords: Glucagon; Glucagon-like peptides; GLP-1; GLP-2; Glucagon receptors; Evolution; Genomics; Fish;
Keywords: BMI; Body Mass Index; mTOR; Mechanistic target of Rapamycin; NOD; New onset diabetes; HbA1c; Hemoglobin A1c; ADT; Androgen Deprivation Therapy; GLP-1; Glucagon Like peptide; CVD; Cardiovascular disease; HIV; Human Immunodeficiency Virus; LDL; Low density
Keywords: ADA; American Diabetes Association; BMI; body mass index; CGM; continuous glucose monitoring; DPP-4; dipeptidyl peptidase 4; GLP-1; glucagon-like peptide 1; mTORC1/2; mammalian target of rapamycin complex 1/2; OGTT; oral glucose tolerance test; PTDM; post
Keywords: AGEs; Advanced glycation end products; ADMA; Asymmetric dimethylarginine; cAMP; Cyclic adenosine monophosphate; DPP-4; Dipeptidyl peptidase 4; GLP-1; Glucagon-like peptide 1; GLP-1R; Glucagon-like peptide 1 receptor; HMGB-1; High mobility group box 1 prot
Keywords: GLP-1; Insulin; Nodose ganglion; Combination; Synergy; Diabetes;
Keywords: Ileal brake; Protein; Amino acid absorption; AAs; amino acids; AUC; area under the curve; ANOVA; mixed analysis of variance; C; control; CRP; C-reactive protein; CV; coefficient of variation; GI; gastrointestinal; GLP-1; glucagon-like peptide 1; PYY; pept
Keywords: Acute pancreatitis; Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonists; Incretin-based therapies; Pancreatic cancer; AERS; Adverse Event Reporting System; CI; confidence interval; DCSI; Diabetes Complication Severity Index; DM; d
Keywords: AP; area postrema; DMV; dorsal motor nucleus of the vagus; DSG; dorsal swallowing group; DVC; dorsal vagal complex; L-DVC; lateral part of the DVC; M-DVC; medial part of the DVC; GLP-1; glucagon like peptide-1; NTS; nucleus tractus solitarius; cNTS; commi
Keywords: β-Glucans; Inflammation; PYY; GLP-1; GLP-2; Ghrelin; Glucose; Insulin; Cancer;
Keywords: Aptides; Exenatide; Human serum albumin; Fusion peptide; GLP-1; Type 2 diabetes;
Keywords: Synthetic biology; Cell-based device; Synthetic receptor; Immunotherapy; Robustness; Intercellular variation; CAR; Chimeric antigen receptor; GLP-1; Glucagon-like peptide-1; HEK; Human embryonic kidney; IL; Interleukin; iPSC; Induced pluripotent stem cell
Keywords: CHF; chronic heart failure; ROS; reactive oxygen species; TGA; triglycerides; FAO; fatty acid β oxidation; PDH; pyruvate dehydrogenase; TCA; tricarboxylic acid; ATP; adenosine triphosphate; ADP; adenosine diphosphate; GDP; guanosine diphosphate; OXPHOS;
Glyceollins: Soybean phytoalexins that exhibit a wide range of health-promoting effects
Keywords: 3T3-L1; mouse fibroblast cell line; 4CL; 4-coumarate:coenzyme A ligase; ABTS; 2,2â²-azinobis(3-ethylbenzthiazoline-6-sulfonate); ACC; acetyl-coA carboxylase; AKT; protein kinase B; AMPK; adenosine-monophosphate kinase; Ang-1; angiopoietin-1; BCRP; breast
Keywords: Arthralgia; Dipeptidyl peptidase-4 inhibitors; Meta-analysis; Systematic review; DPP-4; Dipeptidyl peptidase-4; FDA; Food and Drug Administration; GIP; Glucose-dependent insulinotropic peptide; GLP-1; Glucagon-like peptide-1; IDF; International Diabetes F
Keywords: GLP-1; Thyroidectomy; β-catenin; Hepatic steatosis;
Keywords: Single cell RNA seq; GLP-1; PPG-cells; L-cells; Mass spectrometry; 5-HT;
South American herbal extracts reduce food intake through modulation of gastrointestinal hormones in overweight and obese women
Keywords: GLP-1; glucagon-like peptide 1; YGD; herbal extract combination containing yerba mate, guarana and damiana; AUC; area under the curve; NPY/AgRP; neuropeptide Y/Agouti-related peptide; POMC; pro-opiomelanocortin; BMI; body mass index; WC; waist circumferen
Keywords: GLP-1; Estrogens; Food intake; Meal pattern; c-Fos;
Keywords: cAMP; Diabetes; Glucagon; GLP-1; Inflammation;
Keywords: Bone; GIP; GLP-1; Incretins; Digestive hormones; Os; GIP; GLP-1; Incrétines; Hormones digestives;
Keywords: GLP-2; GLP-1; Amino acid absorption; Rapamycin; Gut peptides; mTORC1; mechanistic target of rapamycin complex 1; 4E-BP1; eukaryotic translation initiation factor 4E (eIF4e)-binding protein 1; GLP-1; Glucagon-like peptide-1; AA; amino acid; LC-MS/MS; liqui
Keywords: Type 1 diabetes; DPP-4; GLP-1; Incretin;
Keywords: CMR; cardiac magnetic resonance imaging; EF; ejection fraction; AMI; acute myocardial infarction; GLP-1; glucagon-like peptide-1; GLUT; glucose transporter; BNIP3; Bcl-2 19-kDa protein-interacting protein 3; p38 MAPK; p38 mitogen-activated protein kinases
Keywords: Sleeve gastrectomy; Biliopancreatic diversion with duodenal switch; Insulin sensitivity; β-cell function; Type 2 diabetes remission; BMI; body mass index; T2D; type 2 diabetes; DI; disposition index; RYGB; Roux-in-Y gastric bypass; SG; sleeve gastrectomy
Keywords: AMPK; 5â² adenosine monophosphate-activated protein kinase; AGE; advanced glycation end-product; BP; blood pressure; CE; cinnamon extracts; CP; cinnamon polyphenols; DM; diabetes mellitus; eNOS; endothelial nitric oxide synthase; FBG; fasting blood gluco
Keywords: BMI; Weight Loss Procedure; Gastric Restriction; Stomach; BMI; body mass index; BTA; botulinum toxin A; ESG; endoscopic sleeve gastroplasty; EWL; excessive weight loss; GLP-1; glucagon-like peptide 1; PYY; peptide YY; RYGB; Roux-en-Y gastric bypass;
Keywords: 2-AI; 2-aminoindane; 2C-B; 2,5-dimethoxy-4-bromophenethylamine; 5-IAI; 5-iodo-2-aminoindane; COMT; catechol-O-methyl transferase; CPP; conditioned place preference; DAT; dopamine transporter; DIO; diet-induced obese; DMT; N,N-dimethyltryptamine; EAAT2; ex
Keywords: AD; Alzheimer's disease; Aβ; amyloid-β; APP; amyloid-β precursor protein; ApoE-ε4; apolipoprotein E-ε4; BBB; blood-brain barrier; CTF; C-terminal fragment; DMN; default mode network; ER; endoplasmic reticulum; GLP-1; glucagon-like peptide-1; GLP-
Keywords: Diabetes mellitus; Glucagon-like peptide-1 agonists; Microvascular events; Macrovascular events; Retinopathy; Nephropathy; Cardiovascular events; GLP-1; Glucagon-like peptide-1; DM; Type 2 diabetes mellitus; CV; Cardiovascular; MI; Myocardial Infarction;
Keywords: Gastric emptying; Dietary carbohydrates; Crossover trial; Digestion; Starch; CFU; colony-forming units; CPDR; cumulative percent dose recovery; GLP-1; glucagon-like peptide 1; PDR; percent dose recovery; SD; standard deviation; SDC; slowly digestible carb
Keywords: Metabolically healthy obesity; Insulin-resistant/sensitive obese; Hormones; Homeostasis model of insulin resistance; Predictors of insulin sensitivity; BMI; body mass index; COPAT; Childhood Obesity Prevalence And Treatment; DHEAS; dehydroepiandrosterone
Keywords: AA; amino acid; ADFI; average daily feed intake; ADG; average daily gain; Ala; alanine; ANFs; anti-nutritive factors; Asn; asparagine; Asp; aspartate; CaSR; calcium sensing receptor; CCK; cholecystokinin; CD36; cluster of differentiation 36; dlM; dl-methi
Keywords: AMEn; apparent metabolizable energy (nitrogen corrected); gut; gastrointestinal tract; CCK; cholecystokinin; PYY; Peptide YY; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-like peptide-2; Broilers; Laying hens; Energy homeostasis; Genotype; Feed form; E
Keywords: Amino acids; Exercise; Hypoglycemia; Hyperinsulinemic-euglycemic clamp clamp; Stable isotopes; GLP-1;
Keywords: DLK1; delta-like 1 homolog; DOHaD; developmental origins of health and disease, DPP-4, dipeptidyl peptidase-4; ERK; extracellular signal-regulated kinase; GGCX; γ-glutamyl carboxylase; GLP-1; glucagon-like peptide-1; GlaOC; γ-carboxylated osteocalcin; G
Keywords: Enteroendocrine Cells; Obesity; Gastrointestinal Peptides; Apo A-IV; apolipoprotein A-IV; BA; bile acids; CB1R; cannabinoid receptor 1 receptor CB1R; CCK; cholecystokinin; CCK-1R; CCK-1 receptor; CNS; central nervous system; DAG; des-acyl ghrelin; DIO; di
Keywords: Exenatide; GLP-1; Glucagon-like peptide-1 receptor agonist; Type 2 diabetes; Long-term efficacy and safety Pooled analysis;
Keywords: Short-Chain Fatty Acids; Prebiotics; Microbial Obesity; Metabolic Control; BMI; body mass index; CID; clinical investigation day; FFA; free fatty acid; GLP-1; glucagon-like peptide-1; GOS; galacto-oligosaccharides; HITChip; Human Intestinal Tract Chip; IL
Keywords: Genistein; Morris water maze; Nitric oxide; IL-1β; TNF-α; AChE; acetylcholinesterase; ANCOVA; analysis of co-variance; ChE; cholinesterase; DACD; diabetes associated cognitive decline; DMSO; dimethyl sulfoxide; DNA; deoxyribonucleic acid; DPP-4; dipepti
Keywords: Gut-Kidney axis; Inflammation; Kidney injury; Short-chain fatty acids; AKI; acute kidney injury; βarrs; β-arrestins; cAMP; cyclic adenosine monophosphate; CKD; chronic kidney disease; CIN; contrast-induced nephropathy; ESRD; end-stage renal disease; E
Keywords: Sucralose; Glucose homeostasis; OGTT; Healthy volunteers; AUC; area under the curve; EFSA; European Food Safety Authority; HbA1C; glycated hemoglobin; GIP; gastric inhibitory peptide; GLP-1; glucagon-like peptide 1; GLUT2; apical glucose transporter type
Keywords: Basal plus; Insulin intensification; Hypoglycaemia; GLP-1; Recommendations;
Keywords: central sleep apnea; diabetic complications; gestational diabetes; OSA; sleep apnea; type 1 diabetes; type 2 diabetes; weight loss; AHI; apnea-hypopnea index; GLP-1; glucagon-like peptide 1; HbA1c; hemoglobin A1c; HOMA; homeostatic model assessment; IVGTT
Keywords: Bile Acids; FXR; TGR5; Meta-Inflammation; apo; apolipoprotein; ASBT; apical sodiumâdependent bile acid transporter; BA; bile acid; BAS; bile acid sequestrant; BAT; brown adipose tissue; BSH; bile salt hydrolase; CA; cholic acid; CCK; cholecystokinin; CD
Keywords: Macrophage; Adipose; Inflammation; Obesity; Fibrosis; Insulin; AMPK; AMP-activated protein kinase; ATM; adipose tissue macrophages; CRP; C-reactive protein; DIO; diet-induced obesity; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GLP-1; glucagon-l